Vg Life Sciences Stock Analysis

VGLS Stock  USD 0.0001  0.00  0.00%   
Vg Life Sciences is overvalued with Real Value of 6.3E-5 and Hype Value of 1.0E-4. The main objective of Vg Life pink sheet analysis is to determine its intrinsic value, which is an estimate of what Vg Life Sciences is worth, separate from its market price. There are two main types of Vg Life's stock analysis: fundamental analysis and technical analysis.
The Vg Life pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vg Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

VGLS Pink Sheet Analysis Notes

The company recorded a loss per share of 0.07. Vg Life Sciences had not issued any dividends in recent years. The entity had 1:600 split on the 27th of November 2012. VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd. VG Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.The quote for Vg Life Sciences is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call the company at 805 879 9000 or visit https://www.vglifesciences.com.

Vg Life Sciences Investment Alerts

Vg Life Sciences is way too risky over 90 days horizon
Vg Life Sciences has some characteristics of a very speculative penny stock
Vg Life Sciences appears to be risky and price may revert if volatility continues
Vg Life Sciences currently holds 3.38 M in liabilities. Vg Life Sciences has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Vg Life until it has trouble settling it off, either with new capital or with free cash flow. So, Vg Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vg Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for VGLS to invest in growth at high rates of return. When we think about Vg Life's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (6.19 M) with profit before overhead, payroll, taxes, and interest of 0.
Vg Life Sciences currently holds about 22.92 K in cash with (1.91 M) of positive cash flow from operations.

VGLS Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vg Life's market, we take the total number of its shares issued and multiply it by Vg Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 1st of February, Vg Life owns the Mean Deviation of 125.33, standard deviation of 254.59, and Risk Adjusted Performance of 0.2077. Compared to fundamental indicators, the technical analysis model makes it possible for you to check helpful technical drivers of Vg Life Sciences, as well as the relationship between them. Please validate Vg Life Sciences risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and kurtosis to decide if Vg Life Sciences is priced fairly, providing market reflects its prevailing price of 1.0E-4 per share. As Vg Life Sciences appears to be a penny stock we also recommend to double-check its jensen alpha numbers.

Vg Life Sciences Price Movement Analysis

Execute Study
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Vg Life middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Vg Life Sciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Vg Life Outstanding Bonds

Vg Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Vg Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most VGLS bonds can be classified according to their maturity, which is the date when Vg Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Vg Life Predictive Daily Indicators

Vg Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Vg Life pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Vg Life Forecast Models

Vg Life's time-series forecasting models are one of many Vg Life's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vg Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About VGLS Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Vg Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling VGLS shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Vg Life. By using and applying VGLS Pink Sheet analysis, traders can create a robust methodology for identifying VGLS entry and exit points for their positions.
VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd. VG Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Vg Life to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Financial Widgets Now

   

Financial Widgets

Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
All  Next Launch Module

Additional Tools for VGLS Pink Sheet Analysis

When running Vg Life's price analysis, check to measure Vg Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vg Life is operating at the current time. Most of Vg Life's value examination focuses on studying past and present price action to predict the probability of Vg Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vg Life's price. Additionally, you may evaluate how the addition of Vg Life to your portfolios can decrease your overall portfolio volatility.